Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders

Julien Matricon, Andrea Giuffrida

Producción científica: Chapter

1 Cita (Scopus)


The endocannabinoid system timely orchestrates a variety of cerebral physiological processes by modulating brain neurotransmitters, and in particular the dopamine system. Both endocannabinoid and dopamine receptors are highly abundant and often coexpressed in the basal ganglia and mesolimbic pathways, where they regulate motor functions and motivational aspects of behavior. Understanding the interrelationship between these two systems is crucial to gain new insight on the pathophysiology of brain disorders characterized by a dysregulation of dopamine, such as Parkinson's disease and schizophrenia. This review aims at: (1) presenting the complex functional interactions between these two neurotransmitter systems at the anatomical, pharmacological, cellular and electrophysiological levels, and (2) addressing the contribution of disturbances of cannabinoid-dopamine interactions to neurodegenerative and psychiatric disorders.

Idioma originalEnglish (US)
Título de la publicación alojadaEndocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
EditorialSpringer New York
Número de páginas29
ISBN (versión digital)9781461479406
ISBN (versión impresa)1461479398, 9781461479390
EstadoPublished - nov 1 2013

ASJC Scopus subject areas

  • General Medicine
  • General Neuroscience


Profundice en los temas de investigación de 'Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders'. En conjunto forman una huella única.

Citar esto